ACTA1 and pulmonary fibrosis: Many studies investigating the treatment of pulmonary fibrosis with Tet have revealed that the pathological characteristics of pulmonary fibrosis are similar to those of development of corneal haze, such as the abnormal accumulation of ECM and α-SMA in myofibroblasts [30,31].